107 related articles for article (PubMed ID: 11160886)
1. Specific down-regulation of an engineered human cyclin D1 promoter by a novel DNA-binding ligand in intact cells.
Laurance ME; Starr DB; Michelotti EF; Cheung E; Gonzalez C; Tam AW; Deikman J; Edwards CA; Bardwell AJ
Nucleic Acids Res; 2001 Feb; 29(3):652-61. PubMed ID: 11160886
[TBL] [Abstract][Full Text] [Related]
2. Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis.
Albanese C; D'Amico M; Reutens AT; Fu M; Watanabe G; Lee RJ; Kitsis RN; Henglein B; Avantaggiati M; Somasundaram K; Thimmapaya B; Pestell RG
J Biol Chem; 1999 Nov; 274(48):34186-95. PubMed ID: 10567390
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
4. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
6. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
Tetsu O; McCormick F
Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the cyclin D1/E2F pathway by PCA-4230, a potent repressor of cellular proliferation.
Goukassian D; Sanz-González SM; Pérez-Roger I; Font de Mora J; Ureña J; Andrés V
Br J Pharmacol; 2001 Apr; 132(7):1597-605. PubMed ID: 11264255
[TBL] [Abstract][Full Text] [Related]
8. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
Hsiang CH; Straus DS
Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
[TBL] [Abstract][Full Text] [Related]
9. Induction of transcripts derived from promoter III of the acetyl-CoA carboxylase-alpha gene in mammary gland is associated with recruitment of SREBP-1 to a region of the proximal promoter defined by a DNase I hypersensitive site.
Barber MC; Vallance AJ; Kennedy HT; Travers MT
Biochem J; 2003 Oct; 375(Pt 2):489-501. PubMed ID: 12871210
[TBL] [Abstract][Full Text] [Related]
10. Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF.
Fang D; Tsuji Y; Setaluri V
Nucleic Acids Res; 2002 Jul; 30(14):3096-106. PubMed ID: 12136092
[TBL] [Abstract][Full Text] [Related]
11. Basal transcriptional regulation of human damage-specific DNA-binding protein genes DDB1 and DDB2 by Sp1, E2F, N-myc and NF1 elements.
Nichols AF; Itoh T; Zolezzi F; Hutsell S; Linn S
Nucleic Acids Res; 2003 Jan; 31(2):562-9. PubMed ID: 12527763
[TBL] [Abstract][Full Text] [Related]
12. Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element.
Verrijdt G; Schoenmakers E; Alen P; Haelens A; Peeters B; Rombauts W; Claessens F
Mol Endocrinol; 1999 Sep; 13(9):1558-70. PubMed ID: 10478846
[TBL] [Abstract][Full Text] [Related]
13. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
Kim HG; Miller DM
Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417
[TBL] [Abstract][Full Text] [Related]
14. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
Saxena D; Yiu GK; Ni X; Huang KC; Mantovani R; Jacquemin-Sablon AG; Ng SW
Gene; 2004 Nov; 342(1):145-55. PubMed ID: 15527974
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of the androgen receptor gene promoter by NFI and an adjacently located multiprotein-binding site.
Song CS; Jung MH; Supakar PC; Chatterjee B; Roy AK
Mol Endocrinol; 1999 Sep; 13(9):1487-96. PubMed ID: 10478840
[TBL] [Abstract][Full Text] [Related]
16. The Sp family of transcription factors in the regulation of the human and mouse MUC2 gene promoters.
Aslam F; Palumbo L; Augenlicht LH; Velcich A
Cancer Res; 2001 Jan; 61(2):570-6. PubMed ID: 11212251
[TBL] [Abstract][Full Text] [Related]
17. Kaiso represses the cell cycle gene cyclin D1 via sequence-specific and methyl-CpG-dependent mechanisms.
Donaldson NS; Pierre CC; Anstey MI; Robinson SC; Weerawardane SM; Daniel JM
PLoS One; 2012; 7(11):e50398. PubMed ID: 23226276
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of the human Cdc2L1 gene promoter.
Kahle A; Feng Y; A Nelson M
Gene; 2005 Jan; 344():53-60. PubMed ID: 15656972
[TBL] [Abstract][Full Text] [Related]
19. An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors.
Bailly A; Torres-Padilla ME; Tinel AP; Weiss MC
Nucleic Acids Res; 2001 Sep; 29(17):3495-505. PubMed ID: 11522818
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of the PXR gene: identification and characterization of a functional peroxisome proliferator-activated receptor alpha binding site within the proximal promoter of PXR.
Aouabdi S; Gibson G; Plant N
Drug Metab Dispos; 2006 Jan; 34(1):138-44. PubMed ID: 16243957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
